Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
January 15, 2025
Blood Eosinophil Count Stability in COPD and the Eosinophilic Exacerbator Phenotype
Federico Baraldi, Samuel Bartlett-Pestle, James P Allinson, et al.
ERJ Open Research
|
December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study
Lydia J Finney, Stefan Avey, Dexter Wiseman, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 19, 2018
Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease
Lydia J Finney, Kylie B R Belchamber, Peter S Fenwick, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 21, 2023
Reply to Martinez-Garcia <i>et al.</i> and to Wang <i>et al.</i>
James P Allinson, Ben H Vlies, Simon E Brill, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 5, 2024
Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease
Oliver W Meldrum, Gavin C Donaldson, Jayanth Kumar Narayana, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 14, 2023
A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
James P Allinson, Ben H Vlies, Simon E Brill, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease
Lydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
The Journal of Allergy and Clinical Immunology
|
October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 22, 2026
Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary Disease
Federico Baraldi, Jordina S Y Mah, Abdulrahman Almuhanna, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial
Andrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
American Journal of Respiratory and Critical Care Medicine
|
January 15, 2025
Blood Eosinophil Count Stability in COPD and the Eosinophilic Exacerbator Phenotype
Federico Baraldi, Samuel Bartlett-Pestle, James P Allinson, et al.
ERJ Open Research
|
December 28, 2023
Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study
Lydia J Finney, Stefan Avey, Dexter Wiseman, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 19, 2018
Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease
Lydia J Finney, Kylie B R Belchamber, Peter S Fenwick, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 21, 2023
Reply to Martinez-Garcia <i>et al.</i> and to Wang <i>et al.</i>
James P Allinson, Ben H Vlies, Simon E Brill, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 5, 2024
Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease
Oliver W Meldrum, Gavin C Donaldson, Jayanth Kumar Narayana, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 14, 2023
A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
James P Allinson, Ben H Vlies, Simon E Brill, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease
Lydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
The Journal of Allergy and Clinical Immunology
|
October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 22, 2026
Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary Disease
Federico Baraldi, Jordina S Y Mah, Abdulrahman Almuhanna, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial
Andrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Page
of 3